<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000752243">
  <TermName>OEPA regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination that is often used with radiation therapy to treat a certain type of childhood Hodgkin lymphoma in males. It includes the drugs vincristine sulfate (Oncovin), etoposide, prednisone, and doxorubicin hydrochloride (Adriamycin). Also called OEPA.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000754484" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;OEPA regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000754483" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen OEPA&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen OEPA</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que a menudo se usa con la radioterapia para el tratamiento del linfoma de Hodgkin infantil en varones. Incluye los medicamentos sulfato de vincristina (Oncovin), etopósido, prednisona y clorhidrato de doxorrubicina (Adriamycin). También se llama OEPA.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2013-09-20</DateFirstPublished>
</GlossaryTerm>
